The FOXM1 gene was the top gene most frequently associated with adverse risk in a pan-cancer analysis of 18,000 human tumors, and it outperformed MK167, which encodes the clinically used proliferation marker Ki-67 [40]. Here, FOXM1 is linked to cancer.